FDA, NIH Issue Joint Clinical Development Glossary
This article was originally published in The Gray Sheet
Executive Summary
The glossary includes terms commonly used in medical product development, with a focus on endpoints and biomarkers. NIH and FDA say they will employ the glossary to ensure consistent communications.